Booster Therapeutics is a company headquartered in Germany.
Booster Therapeutics develops small molecule drugs that activate the 20S proteasome to enhance the body's natural protein degradation process, targeting degenerative diseases such as neurodegenerative disorders.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.